Olga Vasiljeva

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (8)

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Alvaro Teijeira

Centro de Investigación Médica Aplicada, Universidad de Navarra

SPAIN

View details

Thomas Reinheckel

Professor

University of Freiburg

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Olga Vasiljeva

Research Interests

Explore related searches

Contact this professor

Articles (8)

Conditional PD-1/PD-L1 Probody Therapeutics Induce Comparable Antitumor Immunity but Reduced Systemic Toxicity Compared with Traditional Anti-PD-1/PD-L1 Agents.

Novel Ex Vivo Zymography Approach for Assessment of Protease Activity in Tissues with Activatable Antibodies.

First-in-Human Study of the Biodistribution and Pharmacokinetics of <sup>89</sup>Zr-CX-072, a Novel Immunopet Tracer Based on an Anti-PD-L1 Probody.

Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeutic.

Analyzing the Role of Proteases in Breast Cancer Progression and Metastasis Using Primary Cells from Transgenic Oncomice.

The tumor targeting performance of anti-CD166 Probody drug conjugate CX-2009 and its parental derivatives as monitored by <sup>89</sup>Zr-immuno-PET in xenograft bearing mice.

Monitoring protease activity in biological tissues using antibody prodrugs as sensing probes.

Probody Therapeutic Design of <sup>89</sup>Zr-CX-072 Promotes Accumulation in PD-L1-Expressing Tumors Compared to Normal Murine Lymphoid Tissue.

Collaborators (2)

Alvaro Teijeira

Thomas Reinheckel

Make your next move.